JP6864131B1 - Ｌ−エルゴチオネイン含有組成物 - Google Patents

Ｌ−エルゴチオネイン含有組成物 Download PDF

Info

Publication number
JP6864131B1
JP6864131B1 JP2020036577A JP2020036577A JP6864131B1 JP 6864131 B1 JP6864131 B1 JP 6864131B1 JP 2020036577 A JP2020036577 A JP 2020036577A JP 2020036577 A JP2020036577 A JP 2020036577A JP 6864131 B1 JP6864131 B1 JP 6864131B1
Authority
JP
Japan
Prior art keywords
egt
dth
mass
composition
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020036577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021138640A (ja
Inventor
豪 仲谷
豪 仲谷
菜々実 仲島
菜々実 仲島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagase and Co Ltd
Original Assignee
Nagase and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2020036577A priority Critical patent/JP6864131B1/ja
Application filed by Nagase and Co Ltd filed Critical Nagase and Co Ltd
Priority to CA3170408A priority patent/CA3170408A1/en
Priority to TW110107636A priority patent/TW202146013A/zh
Priority to CN202180018596.6A priority patent/CN115209895A/zh
Priority to BR112022017415-2A priority patent/BR112022017415B1/pt
Priority to JP2022504452A priority patent/JPWO2021177397A1/ja
Priority to EP21764176.0A priority patent/EP4115881A4/en
Priority to US17/905,626 priority patent/US12357614B2/en
Priority to KR1020227033764A priority patent/KR20220149718A/ko
Priority to PCT/JP2021/008388 priority patent/WO2021177397A1/ja
Application granted granted Critical
Publication of JP6864131B1 publication Critical patent/JP6864131B1/ja
Publication of JP2021138640A publication Critical patent/JP2021138640A/ja
Priority to JP2025183259A priority patent/JP2026021447A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
JP2020036577A 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物 Active JP6864131B1 (ja)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP2020036577A JP6864131B1 (ja) 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物
KR1020227033764A KR20220149718A (ko) 2020-03-04 2021-03-04 L-에르고티오네인 함유 조성물
CN202180018596.6A CN115209895A (zh) 2020-03-04 2021-03-04 含l-麦角硫因的组合物
BR112022017415-2A BR112022017415B1 (pt) 2020-03-04 2021-03-04 Composição contendo l-ergotioneína
JP2022504452A JPWO2021177397A1 (https=) 2020-03-04 2021-03-04
EP21764176.0A EP4115881A4 (en) 2020-03-04 2021-03-04 COMPOSITION CONTAINING L-ERGOTHIONEINE
CA3170408A CA3170408A1 (en) 2020-03-04 2021-03-04 L-ergothioneine-containing composition
TW110107636A TW202146013A (zh) 2020-03-04 2021-03-04 含l-麥角硫鹼的組成物
PCT/JP2021/008388 WO2021177397A1 (ja) 2020-03-04 2021-03-04 Ｌ－エルゴチオネイン含有組成物
US17/905,626 US12357614B2 (en) 2020-03-04 2021-03-04 L-ergothioneine-containing composition
JP2025183259A JP2026021447A (ja) 2020-03-04 2025-10-30 Ｌ－エルゴチオネイン含有組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020036577A JP6864131B1 (ja) 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物

Publications (2)

Publication Number Publication Date
JP6864131B1 true JP6864131B1 (ja) 2021-04-28
JP2021138640A JP2021138640A (ja) 2021-09-16

Family

ID=75638746

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2020036577A Active JP6864131B1 (ja) 2020-03-04 2020-03-04 Ｌ−エルゴチオネイン含有組成物
JP2022504452A Pending JPWO2021177397A1 (https=) 2020-03-04 2021-03-04
JP2025183259A Pending JP2026021447A (ja) 2020-03-04 2025-10-30 Ｌ－エルゴチオネイン含有組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022504452A Pending JPWO2021177397A1 (https=) 2020-03-04 2021-03-04
JP2025183259A Pending JP2026021447A (ja) 2020-03-04 2025-10-30 Ｌ－エルゴチオネイン含有組成物

Country Status (8)

Country Link
US (1) US12357614B2 (https=)
EP (1) EP4115881A4 (https=)
JP (3) JP6864131B1 (https=)
KR (1) KR20220149718A (https=)
CN (1) CN115209895A (https=)
CA (1) CA3170408A1 (https=)
TW (1) TW202146013A (https=)
WO (1) WO2021177397A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118215476A (zh) * 2021-11-08 2024-06-18 三菱瓦斯化学株式会社 用于抑制或预防内耳性耳聋的含有麦角硫因的组合物
KR20240127428A (ko) * 2021-12-23 2024-08-22 산토리 홀딩스 가부시키가이샤 경구 조성물 및 소프트 캡슐제
CN121311472A (zh) * 2023-06-15 2026-01-09 长濑产业株式会社 化合物或其盐及其制造方法、组合物、过氧化氢清除剂以及细胞毒性抑制剂
WO2025142813A1 (ja) * 2023-12-27 2025-07-03 サントリーホールディングス株式会社 経口組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2707086A1 (fr) * 1993-06-28 1995-01-06 Bioxytech Procédé de préparation de l'ergothionéine.
DE102004020714A1 (de) * 2004-04-26 2005-11-10 Beiersdorf Ag Haut- und/oder Haarmittel enthaltend Verbindungen mit isoprenoider Struktur
FR2910808B1 (fr) * 2006-12-29 2009-04-10 Lvmh Rech Utilisation en cosmetique de la l-2-thiohistidine ou d'un de ses derives comme agent depigmentant.
US7767826B2 (en) 2007-10-05 2010-08-03 Pharmatech International, Inc. Process for the synthesis of L-(+)-ergothioneine
JP2009126863A (ja) * 2007-11-27 2009-06-11 Koei Kogyo Kk キノコから抽出したエルゴチオネインを高含有する組成物
FR2950889B1 (fr) * 2009-10-06 2011-11-18 Tetrahedron Procede de synthese de l'ergothioneine et analogues
FR2950890B1 (fr) * 2009-10-06 2011-12-30 Tetrahedron Procede de synthese de la 2-thiohistidine et analogues
AU2013234815B2 (en) 2012-03-23 2017-06-22 The University Of Queensland Immunomodulatory agent and uses therefor
GB201416678D0 (en) * 2014-09-22 2014-11-05 Univ Cape Town Process For Synthesizing Ergothioneine And Its Intermediates
EP3252142B1 (en) * 2015-01-30 2021-11-03 Kikkoman Corporation Transformed fungus having enhanced ergothioneine productivity and method for producing ergothioneine
WO2019089878A1 (en) 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation
US11098330B2 (en) 2018-02-23 2021-08-24 Nagase & Co., Ltd. Method for producing ergothioneine
JP7185213B2 (ja) * 2018-03-02 2022-12-07 国立大学法人 筑波大学 エルゴチオネイン合成微生物、及びエルゴチオネインの製造方法

Also Published As

Publication number Publication date
JPWO2021177397A1 (https=) 2021-09-10
CA3170408A1 (en) 2021-09-10
CN115209895A (zh) 2022-10-18
JP2021138640A (ja) 2021-09-16
EP4115881A4 (en) 2024-04-03
EP4115881A1 (en) 2023-01-11
TW202146013A (zh) 2021-12-16
BR112022017415A2 (pt) 2022-10-18
JP2026021447A (ja) 2026-02-10
WO2021177397A1 (ja) 2021-09-10
KR20220149718A (ko) 2022-11-08
US12357614B2 (en) 2025-07-15
US20230126387A1 (en) 2023-04-27

Similar Documents

Publication Publication Date Title
JP6864131B1 (ja) Ｌ−エルゴチオネイン含有組成物
JP2008179632A (ja) 抗酸化剤
JP2009126863A (ja) キノコから抽出したエルゴチオネインを高含有する組成物
JP2011032171A (ja) 美白用組成物
JP2014508139A (ja) フラボン系化合物の新規な用途
JP2008239619A (ja) 末梢血行改善組成物
TW201343189A (zh) 含牛蒡苷元衍生物之抗老化劑
JP4828922B2 (ja) 抗アレルギー剤
TWI308152B (https=)
JP6902329B2 (ja) 皮脂腺細胞の活性化の抑制剤
JPWO2015083554A1 (ja) ４Ｇ−Ｏ−α−Ｄ−グルコピラノシルルチンの結晶とその用途
KR20150027008A (ko) 모노아세틸디아실글리세롤 화합물을 유효성분으로 함유하는 아토피 피부염의 예방 또는 치료용 조성물
JP7240565B2 (ja) Ｌ－エルゴチオネイン含有組成物
KR101819670B1 (ko) 피부질환 예방 또는 치료용 조성물
JP7727671B2 (ja) ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
JP6456032B2 (ja) Ｓｉｒｔ１活性化剤および当該Ｓｉｒｔ１活性化剤の利用
BR112022017415B1 (pt) Composição contendo l-ergotioneína
BR122023019667B1 (pt) Método de produção de uma composição contendo l-ergotioneína e n, n-dimetil-l-2-tiohistidina e método de supressão de coloração da composição
HK40075066A (en) L-ergothioneine-containing composition
KR102751353B1 (ko) 바닐린을 유효성분으로 함유하는 항진균용 조성물
TWI918846B (zh) 升半胱胺酸衍生物及其製造方法、組成物、以及發炎抑制劑
JP2020189816A (ja) ビタミンｃ誘導体組成物
KR20240101435A (ko) 철갑상어 점액질을 유효성분으로 포함하는 발모 촉진용 조성물
KR20180010084A (ko) 3-O-갈로일-3,3',5,5',7-펜타하이드록시플라반(3-O-galloyl-3,3',5,5',7- pentahydroxyflavan)을 포함하는 보습용 조성물
KR20170098182A (ko) 알레르기성 또는 염증성 피부질환의 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20200327

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20200327

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20201022

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20201022

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20201111

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20201201

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20210129

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210310

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210323

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210401

R150 Certificate of patent or registration of utility model

Ref document number: 6864131

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250